Suwa M., et al. Metformin increases the PGC-1alpha protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo. J Appl Physiol (1985). 2006 Dec; 101(6):1685–92. doi:10.1152/ japplphysiol.00255.2006.
Takahashi Y., et al. Hepatic failure and enhanced oxidative stress in mitochondrial diabetes. Endocr J. 2008 Jul; 55(3):509–14. doi:10.1507/ endocrj.K07E-091.
UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998 Sep 12; 352(9131):837–53. doi:10.1016/S0140-6736(98)07019-6.
Vanhorebeek I., et al. Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness. Crit Care Med. 2009 Apr; 37(4):1355–64. doi:10.1097/CCM.0b013e31819cec17.
Vidal-Puig A. J., et al. Energy metabolism in uncoupling protein 3 gene knockout mice. J Biol Chem. 2000 May 26; 275(21):16258–66. doi:10.1074/ jbc.M910179199.
Wang X. et al. Protective effect of oleanolic acid against beta cell dysfunction and mitochondrial apoptosis: crucial role of ERK-NRF2 signaling pathway. J Biol Regul Homeost Agents. 2013 Jan — Mar; 27(1):55–67.
Weksler-Zangen S., et al. Dietary copper supplementation restores α-cell function of Cohen diabetic rats: a link between mitochondrial function and glucose stimulated insulin secretion. Am J Physiol Endocrinol Metab. 2013 May 15; 304(10):E1023–E1034. Epub 2013 Mar 19. doi:10.1152/ ajpendo.00036.2013.
Winder W. W., Hardie D. G. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol. 1999 Jul; 277(1 Pt 1):E1–E10.
Yan W., et al. Impaired mitochondrial biogenesis due to dysfunctional adiponectin AMPKPGC-1α signaling contributing to increased vulnerability in diabetic heart. Basic Res Cardiol. 2013 May;108(3):329. Epub 2013 Mar 5. doi:10.1007/s00395-013-0329-1.
Ye J. Mechanisms of insulin resistance in obesity. Front Med. 2013 Mar; 7(1):14–24. Epub 2013 Mar 9. doi:10.1007/s11684-013-0262-6.
Индуцированные приемом лекарств повреждения митохондрий и соответствующие болезни
Abdoli N., et al. Mechanisms of the statins’ cytotoxicity in freshly isolated rat hepatocytes. J Biochem Mol Toxicol. 2013 Jun; 27(6):287–94. Epub 2013 Apr 23. doi:10.1002/jbt.21485.
Anedda A., Rial E., González-Barroso M. M. Metformin induces oxidative stress in white adipocytes and raises uncoupling protein 2 levels. J Endocrinol. 2008 Oct; 199(1):33–40. Epub 2008 Aug 7. doi:10.1677/ JOE-08-0278.
Balijepalli S., Boyd M. R., Ravindranath V. Inhibition of mitochondrial complex I by haloperidol: the role of thiol oxidation. Neuropharmacology. 1999 Apr; 38(4):567–77. doi:10.1016/S0028-3908(98)00215-9.
Balijepalli S., et al. Protein thiol oxidation by haloperidol results in inhibition of mitochondrial complex I in brain regions: comparison with atypical antipsychotics. Neurochem Int. 2001, 38, 425–35. doi:10.1016/ S0197-0186(00)00108-X.
Beavis A. D. On the inhibition of the mitochondrial inner membrane anion uniporter by cationic amphiphiles and other drugs. J Biol Chem. 1989 Jan 25; 264:1508–15.
Belenky P., Camacho D., Collins J. J. Fungicidal drugs induce a common oxidative-damage cellular death pathway. Cell Rep. 2013 Feb 21; 3(2):350– 8. Epub 2013 Feb 14. doi:10.1016 /j.celrep.2012.12.021.
Berson A., et al. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology. 1998 Apr; 114(4):764–74. doi:10.1016 /S0016-5085(98)70590-6.
Brinkman K., et al. Mitochondrial toxicity induced by nucleoside-analogue reverse transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet. 1999 Sep 25; 354(9184):1112–5. doi:10.1016/S0140-6736(99)06102-4.
Brinkman K., Kakuda T. N. Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy? Curr Opin Infect Dis. 2000 Feb; 13(1):5–11.
Brown S. J., Desmond P. V. Hepatotoxicity of antimicrobial agents. Sem Liver Dis. 2002; 22(2): 157–67. doi:10.1055/s-2002-30103.
Carvalho F. S., et al. Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy. Med Res Rev. 2014 Jan; 34(1):106–35. Epub 2013 Mar 11. doi:10.1002 /med.21280.
Chan K., et al. Drug induced mitochondrial toxicity. Expert Opin Drug Metab Toxicol. 2005 Dec; 1(4):655–69. doi:10.1517/17425255.1.4.655.